Maky Zanganeh

Maky Zanganeh discloses dealings in 2 companies, chiefly Summit Therapeutics Inc. and Pulse Biosciences, Inc. We count 3 filings; the first trade dates from 12 May 2021 and the latest from 16 August 2022.

Purchases make up the whole of the open-market record (2 purchases, €1.9M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 share grant. So far in 2022, the count stands at 1 purchase and no sales.

On 18 August 2022 came the latest disclosure, an open-market purchase for €176k in Summit Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.